United States: Capitol Hill Healthcare Update – January 9, 2018


With less than two weeks before another deadline to avert a government shutdown, Republican leaders on Capitol Hill say they're cautiously optimistic about crafting a budget agreement that also would include several key healthcare provisions.

The budget outline would include setting top-line budget numbers for two fiscal years, a long-term reauthorization of the Children's Health Insurance Program (CHIP), renewal of Medicare payment provisions and a series of changes to Affordable Care Act (ACA) provider taxes. While that framework has been discussed among Republicans and Democrats, congressional staff warn it has not been agreed to and could stall over a number of unrelated issues. For example, some Democrats say they will withhold support for a budget agreement or another stopgap spending bill to keep the government open unless their demands for immigration provisions are met.

Passage of a CHIP renewal should be easier after an estimate last week by the Congressional Budget Office found that a five-year renewal would cost only $800 million, down from earlier estimates of $8.2 billion. CBO said the new forecast comes after Congress approved separate tax legislation last month that repealed the ACA's individual mandate, which the agency found would reduce the government's overall healthcare spending.

Dozens of children's hospital executives are in Washington this week, and they are stepping up criticism of Congress for failing to renew the bipartisan program, which expired last September. They are expected to press lawmakers to vote immediately on a five-year renewal.

Under the tentative budget framework, the ACA taxes that could be targeted for a suspension or even repeal include the medical device tax, the tax on insurers and the so-called Cadillac tax on high-cost health plans. But there's disagreement among congressional Republicans on whether to include the ACA tax provisions now or later in a separate tax-only bill.


The Senate Finance Committee on Tuesday will hold a confirmation hearing on Alex Azar, whom President Donald Trump in November nominated for Health & Human Services (HHS) secretary.

Azar enjoys widespread support among Senate Republicans and is likely to be confirmed. But Democrats on the committee are expected to grill Azar over what they say has been Trump's inaction on prescription drug prices and Azar's role in boosting prices while he was a senior executive at Eli Lilly.

Democrats who are likely to pose the sharpest questions to Azar will be the top committee Democrat, Sen. Ron Wyden, D-Ore., as well as Sens. Bill Nelson, D-Fla., Sherrod Brown, D-Ohio, and Claire McCaskill, D-Mo.

Sen. Chuck Grassley, R-Iowa, is a frequent pharma critic, and he is expected to push Azar on prescription drug importation and on manufacturers that use patent laws to extend drug exclusivity. Grassley last year called on HHS to fast-track the importation of prescription drugs from Canada.

Committee Chairman Orrin Hatch is expected to quickly move for a vote by the full committee, and GOP leaders want to get Azar confirmed by the Senate this month.


Congressional Republicans and President Donald Trump met at Camp David over the weekend to plot their 2018 legislative agenda with House GOP leaders, making the case that a Medicaid overhaul tied to welfare reform would help the party's political fortunes in this year's midterm elections.

House Speaker Paul Ryan has long said he wants to focus on entitlement reforms this year, even using budget reconciliation legislation to force a party-line vote and bypass a Democratic-led filibuster in the Senate. But after failing twice last year to repeal the Affordable Care Act (ACA), Senate Republicans are cool to the idea of tackling even Medicaid reform. Senate Majority Leader Mitch McConnell said a Medicaid overhaul could be approved only with support from Democrats, who oppose GOP efforts to block-grant the program.

Although there isn't a clear path for Republicans to enact broad Medicaid reforms this year, House Republicans are not giving up. Even with McConnell signaling the Senate won't pass a Medicaid bill, the House is expected to draft and vote on a Medicaid reform package. House leaders say Medicaid and welfare reform not only align with conservatives' political outlook but also would boost Republicans as they battle to retain their House majority.

Sen. Lindsay Graham, R-S.C., one of the authors of last year's failed ACA repeal bill, said he will press for a new vote this year on his legislation with Sen. Bill Cassidy, R-La., that among other things would transform Medicaid into a block-grant program. But it's not clear Republicans are any closer to gaining the 50 votes they need. The GOP faces a slimmer majority after losing the Alabama special election in December, and two GOP lawmakers – Sens. John McCain, R-Ariz., and Thad Cochran, R-Miss. – have missed votes in recent months due to illnesses.


The Senate last week approved bipartisan legislation that would expand veterans' access to telehealth services, including mental health treatment.

The bill by Sens. Joni Ernst, R-Iowa, and Mazie Hirono, D-Hawaii, is similar to legislation that won House approval last year.

The Senate bill targets disabled and rural veterans by expanding telehealth services to allow Department of Veterans Affairs' (VA) officials to practice telemedicine across state lines. It also calls on the VA to study the effectiveness of telehealth services with the hope it could be expanded to cover other treatment areas.


The Senate last year approved legislation that would give terminally ill patients wider access to prescription drugs that haven't yet won Food and Drug Administration (FDA) approval, and now a conservative political advocacy group is calling on Republican leaders to schedule a vote in the House.

Americans for Prosperity, which is funded by Republican activist brothers David Koch and Charles Koch, wants House Energy and Commerce Committee Chairman Greg Walden, R-Ore., to schedule a vote on a House version of the bill. In a letter to Walden, the group said the FDA's compassionate use program, which allows terminally ill patients to access experimental drugs, is "costly, onerous and overly complicated."

Vice President Michael Pence last year endorsed the so-called right-to-try legislation backed by Sen. Ron Johnson, R-Wis. Pharmaceutical manufacturers have resisted the bill, saying early access to unapproved drugs could give patients false hope and threatens the integrity of ongoing clinical trials if those patients have adverse reactions.


A group of conservative policy and political activists is calling on congressional Republicans to vote again on repealing the Affordable Care Act (ACA).

The group includes think tanks Heritage Action, the Hoover Institution and the American Enterprise Institute, as well as former Sen. Rick Santorum, R-Pa.

"Health costs are rising faster than before [the ACA], and there's no real prospect of a reversal without legislative action," the group wrote in a letter to Republican congressional leaders.

While a new push to repeal the ACA is unlikely in Congress, the letter reflects political pressure congressional Republicans continue to feel from conservative grassroots activists, who will play a key role in contested House and Senate Republican primary elections that begin next month.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions